Fmc Corp FMC
We take great care to ensure that the data presented and summarized in this overview for FMC CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FMC
View all-
Vanguard Group Inc Valley Forge, PA14.8MShares$205 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$164 Million0.02% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA5.09MShares$70.7 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA5.01MShares$69.6 Million0.03% of portfolio
-
State Street Corp Boston, MA4.84MShares$67.3 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.84MShares$67.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.9MShares$40.3 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA2.66MShares$37 Million0.02% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.5MShares$34.7 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$34.6 Million0.02% of portfolio
Latest Institutional Activity in FMC
Top Purchases
Top Sells
About FMC
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
Insider Transactions at FMC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2025
|
John Mitchell Raines Director |
BUY
Open market or private purchase
|
Direct |
7,000
+33.68%
|
$91,000
$13.77 P/Share
|
|
Nov 05
2025
|
Carol Anthony Davidson Director |
BUY
Open market or private purchase
|
Direct |
10,000
+30.1%
|
$130,000
$13.6 P/Share
|
|
Oct 16
2025
|
Patricia Verduin Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.88%
|
-
|
|
Oct 16
2025
|
John Mitchell Raines Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.86%
|
-
|
|
Oct 16
2025
|
Robert C Pallash Director |
BUY
Grant, award, or other acquisition
|
Direct |
898
+1.47%
|
-
|
|
Oct 16
2025
|
Margareth Oevrum Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+1.34%
|
-
|
|
Oct 16
2025
|
Steven T Merkt Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.71%
|
-
|
|
Oct 16
2025
|
Dirk A Kempthorne Director |
BUY
Grant, award, or other acquisition
|
Direct |
773
+1.35%
|
-
|
|
Oct 16
2025
|
K Lynne Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
427
+1.21%
|
-
|
|
Oct 16
2025
|
C Scott Greer Director |
BUY
Grant, award, or other acquisition
|
Direct |
489
+0.65%
|
-
|
|
Oct 16
2025
|
Kathy Lynn Fortmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
185
+1.28%
|
-
|
|
Oct 16
2025
|
Anthony Disilvestro Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.41%
|
-
|
|
Oct 16
2025
|
Carol Anthony Davidson Director |
BUY
Grant, award, or other acquisition
|
Direct |
142
+1.06%
|
-
|
|
Oct 16
2025
|
Eduardo E Cordeiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.93%
|
-
|
|
Oct 16
2025
|
Pierre R Brondeau Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.03%
|
-
|
|
Sep 29
2025
|
Jacqueline Scanlan Executive VP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,177
-15.67%
|
$170,841
$33.64 P/Share
|
|
Sep 29
2025
|
Jacqueline Scanlan Executive VP & Chief HRO |
SELL
Open market or private sale
|
Direct |
3,790
-10.29%
|
$128,860
$34.0 P/Share
|
|
Aug 18
2025
|
Jacqueline Scanlan Executive VP & Chief HRO |
SELL
Open market or private sale
|
Direct |
1,510
-3.94%
|
$55,870
$37.49 P/Share
|
|
Jul 17
2025
|
Carol Anthony Davidson Director |
BUY
Grant, award, or other acquisition
|
Direct |
113
+0.86%
|
-
|
|
Jul 17
2025
|
Pierre R Brondeau Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
84
+0.03%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 183K shares |
|---|---|
| Open market or private purchase | 82.6K shares |
| Exercise of conversion of derivative security | 2.97K shares |
| Discretionary transaction | 2.59K shares |
| Payment of exercise price or tax liability | 14.6K shares |
|---|---|
| Open market or private sale | 8.26K shares |
| Discretionary transaction | 74 shares |